M. Cercel

Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo

S. H. van der Burg, M. A. Gillissen, A. Bakker, 2020, Cancer Immunology, Immunotherapy.

A chemo-enzymatically linked bispecific antibody retargets T cells to a sialylated epitope on CD43 in acute myeloid leukemia.

M. A. Gillissen, A. Bakker, H. Spits, 2019, Cancer research.

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice

I. B. Borel Rinkes, C. Punt, S. Boj, 2022, Journal for ImmunoTherapy of Cancer.